Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Boston Scientific (NY: BSX )

48.44 +0.11 (+0.22%)
Streaming Delayed Price Updated: 2:40 PM EDT, Mar 28, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,151,459
Open 48.49
Bid (Size) 48.43 (24)
Ask (Size) 48.44 (7)
Prev. Close 48.33
Today's Range 48.10 - 48.87
52wk Range 34.98 - 49.22
Shares Outstanding 1,423,852,648
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Can Healthcare Stocks Survive Macro Headwinds?
Healthcare stocks are supposed to be defensive plays in a choppy market. However, over the past 18 months, the XLV is flat and down 6% over one year. 
Via Talk Markets
Boston Scientific Corp. (NYSE: BSX) Climbs to New 52-Week High
Via Investor Brand Network

Performance

YTD
+5.27%
+5.27%
1 Month
+3.45%
+3.45%
3 Month
+4.75%
+4.75%
6 Month
+26.26%
+26.26%
1 Year
+9.41%
+9.41%

More News

Read More
Looking Into Boston Scientific's Recent Short Interest
Via Benzinga
BOSTON SCIENTIFIC INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Boston Scientific Corporation - BSX
From Kahn Swick & Foti, LLC
Via Business Wire
8 Analysts Have This to Say About Boston Scientific
Via Benzinga
Why Boston Scientific Shares Are Trading Higher Today
Via Benzinga
$1000 Invested In Boston Scientific 10 Years Ago Would Be Worth This Much Today
Via Benzinga
A Preview Of Boston Scientific's Earnings
Via Benzinga
4 Analysts Have This to Say About Boston Scientific
Via Benzinga
What 4 Analyst Ratings Have To Say About Boston Scientific
Via Benzinga
Thermo Fisher Pops On Its Bullish Outlook As Boston Scientific Gains On Its In-Line Report
Via Investor's Business Daily
GE Healthcare Technology: Speculating On Dividends
Via MarketBeat
BOSTON SCIENTIFIC INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Boston Scientific Corporation - BSX
From Kahn Swick & Foti, LLC
Via Business Wire
Clearmind Teams With Yissum, University of Jerusalem On 2 Psychedelic R&D Projects
Via Benzinga
Expert Ratings for Boston Scientific
Via Benzinga
Boston Scientific's Return on Invested Capital Insights
Via Benzinga
Earnings Scheduled For February 1, 2023
Via Benzinga
How Doug Godshall Ignited The Spark At Shockwave
Via Investor's Business Daily
Is Medtronic Stock Ready to Revive?
Via MarketBeat
Topics Economy
Exposures Interest Rates Supply Chain
Benzinga's Top Ratings Upgrades, Downgrades For December 22, 2022
Via Benzinga
2 Smartest Tech Stocks to Buy in 2022 and Beyond
Via The Motley Fool
Week In Review: Boston Scientific Pays $523 Million For Majority Stake In Beijing Acotec Scientific
Via Talk Markets
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Stocks To Eye This Week
Via Talk Markets
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations:) Apollo Endosurgery, Inc. (Nasdaq - APEN), Imago BioSciences, Inc. (Nasdaq - IMGO), Opiant Pharmaceuticals Inc. (Nasdaq - OPNT), Benefitfocus, Inc. (Nasdaq - BNFT)
From Brodsky & Smith LLC
Via Globe NewsWire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.